Viewing nowPM Rosuvastatin Tablets 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.838mg
Tablet · Prescription medication
Pharmascience Korea Co., Ltd.

MFDS item code 201700505 · Approved 2017.01.26 · Insurance code 627600200
Improvement of dyslipidemia, reduction of cardiovascular disease risk, inhibition of atherosclerosis progression
This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia when dietary and exercise management are insufficient. It can also be used in conjunction with other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It helps lower total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. It can also be safely used in pediatric patients with familial hypercholesterolemia who meet certain criteria. This drug is also used as an adjunct to treat patients with primary dysbetalipoproteinemia and contributes to reducing the risk of stroke, myocardial infarction, and artery revascularization in middle-aged and older patients at high risk for cardiovascular diseases. Overall, this drug is an effective treatment option for managing dyslipidemia and reducing the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams once daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. This drug should not be administered to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This drug should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, individuals allergic to any of this drug's ingredients, those with severely impaired liver function, or those with muscle disorders should not take this medication. Additionally, pregnant or breastfeeding women, and fertile women not using adequate contraception should also avoid this drug. This drug should be used with caution in individuals with weak liver function, those who consume excessive alcohol, and individuals with hypothyroidism. Symptoms such as muscle pain or weakness should be reported to a physician immediately, and blood tests may be necessary to check for muscle damage if needed. This drug may cause abnormal liver function tests, so it is important to have regular liver function tests. Furthermore, this drug can raise blood sugar levels, so individuals at risk for diabetes should monitor their blood sugar periodically. This drug may increase blood concentration when taken with certain medications, raising the risk of muscle damage. Therefore, anyone taking other medications should inform their doctor or pharmacist. Pregnant or breastfeeding women should avoid this drug as it may pose risks to the fetus or infant; women planning to become pregnant should use appropriate methods of contraception. In case of overdose, there is no specific antidote; treatment should be tailored to the symptoms, and monitoring of liver function and potential muscle damage is essential. This medication may cause dizziness, so caution is needed when driving or operating machinery. Lastly, this drug may show higher blood concentrations in Asians, which may require dosage adjustment.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air or moisture, at room temperature between 1 to 30 degrees Celsius. Keeping it stored this way helps maintain its effectiveness and prevents degradation.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.838mg
Tablet · Prescription medication
Pharmascience Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.